HopeStage
Back to all studies
CompletedNCT02330068

Gut Microbiome and Response to Citalopram for Depression

About this titleRead the official source — NCT02330068
Observational studyAges 18–55United StatesBipolarity
The study in practice

Understand this study

Who was this study for?

Listed age limits: 18 years to 55 years.

Listed locations
Jacksonville and 1 more locationSee all locations and recruitment

Get this study by email

HopeStage may email me about this study.
Loading the security check...
Study clarity

Study information

Study start dateStarted: December 2014
Recruitment status
Completed
Enrollment listed in the registry
34
Sponsor
Mayo Clinic
Sponsor type
Hospital / academic medical center
Study type
Observational
Intervention type
Drug
Locations
United States
Age range
From 18 Years to 55 Years
Official registry ID
NCT02330068
Official title
Show the full official title

Microbiome of Depression &Amp; Treatment Response to Citalopram: A Feasibility Study

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

Jacksonville · Rochester

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Mayo Clinic, a hospital or academic medical center.

Did this study involve medication?

Yes. The study involved medication, including citalopram.

Who was this study for?

Listed age limits: 18 years to 55 years.

Want to explore more studies?

Explore studies